Neurovascular Devices | Market Insights | Asia Pacific | 2021
Despite the short-term impact of the COVID-19 pandemic, as well as barriers to patients’ access to neurovascular treatments, improving healthcare infrastructure, growing demand, and clinical data supporting the endovascular approach over surgical interventions for treating neurovascular diseases will support procedure volume growth in Asia Pacific countries.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for Neurovascular devices in Asia Pacific across a 10-year period.